NK-cell receptors NKp46 and NCR1 control human metapneumovirus infection

European Journal of Immunology

Volumn 47, Issue 4, 2017, Pages 692-703

  Diab, Mohammad ^a   Glasner, Ariella ^a   Isaacson, Batya ^a   Bar On, Yotam ^a   Drori, Yaron ^b,c   Yamin, Rachel ^a   Duev Cohen, Alexandra ^a   Danziger, Oded ^c   Zamostiano, Rachel ^c   Mandelboim, Michal ^b,c   Jonjic, Stipan ^d   Bacharach, Eran ^c   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

HMPV; MHC class I; MICA; NCR1; NCRs; NK cells; NKG2D; NKp46; respiratory infection

Indexed keywords

CD27 ANTIGEN; CD69 ANTIGEN; HYBRID PROTEIN; INTERLEUKIN 2; LEUKOSIALIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 POLYPEPTIDE RELATED SEQUENCE A; MATRIX PROTEIN; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL KILLER CELL RECEPTOR NKG2D; NUCLEOPROTEIN; PHOSPHOPROTEIN; UNCLASSIFIED DRUG; LY ANTIGEN; NCR1 PROTEIN, HUMAN; NCR1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN METAPNEUMOVIRUS INFECTION; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VERO CELL LINE; VIRUS LOAD; ANIMAL; BAGG ALBINO MOUSE; CHILD; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; INFANT; KNOCKOUT MOUSE; LUNG; LYMPHOCYTE ACTIVATION; METABOLISM; METAPNEUMOVIRUS; PARAMYXOVIRUS INFECTION; VIROLOGY;

ANIMALS; ANTIGENS, LY; CHILD; CYTOTOXICITY, IMMUNOLOGIC; HEK293 CELLS; HUMANS; INFANT; KILLER CELLS, NATURAL; LUNG; LYMPHOCYTE ACTIVATION; METAPNEUMOVIRUS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; PARAMYXOVIRIDAE INFECTIONS; VIRAL LOAD;

EID: 85014697327     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201646756     Document Type: Article

References (63)

1. Raulet, D. H., Vance, R. E. and McMahon, C. W., Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 2001. 19: 291–330.
2. Seidel, E., Glasner, A. and Mandelboim, O., Virus-mediated inhibition of natural cytotoxicity receptor recognition. Cell. Mol. Life Sci. 2012. 69: 3911–3920.
3. Vivier, E., Tomasello, E., Baratin, M., Walzer, T. and Ugolini, S., Functions of natural killer cells. Nat. Immunol. 2008. 9: 503–510.
4. Stanietsky, N., Simic, H., Arapovic, J., Toporik, A., Levy, O., Novik, A., Levine, Z. et al., The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proc. Natl. Acad. Sci. U. S. A. 2009. 106: 17858–17863.
5. Yawata, M., Yawata, N., Draghi, M., Partheniou, F., Little, A. M. and Parham, P., MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response. Blood 2008. 112: 2369–2380.
6. Markel, G., Lieberman, N., Katz, G., Arnon, T. I., Lotem, M., Drize, O., Blumberg, R. S. et al., CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity. J. Immunol. 2002. 168: 2803–2810.
7. Obeidy, P. and Sharland, A. F., NKG2D and its ligands. Int. J. Biochem. Cell Biol. 2009. 41: 2364–2367.
8. Stern-Ginossar, N. and Mandelboim, O., An integrated view of the regulation of NKG2D ligands. Immunology 2009. 128: 1–6.
9. Biassoni, R., Cantoni, C., Pende, D., Sivori, S., Parolini, S., Vitale, M., Bottino, C. et al., Human natural killer cell receptors and co-receptors. Immunol. Rev. 2001. 181: 203–214.
10. Gazit, R., Gruda, R., Elboim, M., Arnon, T. I., Katz, G., Achdout, H., Hanna, J. et al., Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 2006. 7: 517–523.
11. Biassoni, R., Pessino, A., Bottino, C., Pende, D., Moretta, L. and Moretta, A., The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity. Eur. J. Immunol. 1999. 29: 1014–1020.
12. Achdout, H., Meningher, T., Hirsh, S., Glasner, A., Bar-On, Y., Gur, C., Porgador, A. et al., Killing of avian and Swine influenza virus by natural killer cells. J. Virol. 2010. 84: 3993–4001.
13. Mandelboim, O., Lieberman, N., Lev, M., Paul, L., Arnon, T. I., Bushkin, Y., Davis, D. M. et al., Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001. 409: 1055–1060.
14. Mendelson, M., Tekoah, Y., Zilka, A., Gershoni-Yahalom, O., Gazit, R., Achdout, H., Bovin, N. V. et al., NKp46 O-glycan sequences that are involved in the interaction with hemagglutinin type 1 of influenza virus. J. Virol. 2010. 84: 3789–3797.
15. Glasner, A., Zurunic, A., Meningher, T., Lenac Rovis, T., Tsukerman, P., Bar-On, Y., Yamin, R. et al., Elucidating the mechanisms of influenza virus recognition by Ncr1. PLoS One 2012. 7: e36837.
16. Arnon, T. I., Achdout, H., Lieberman, N., Gazit, R., Gonen-Gross, T., Katz, G., Bar-Ilan, A. et al., The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood 2004. 103: 664–672.
17. Jarahian, M., Fiedler, M., Cohnen, A., Djandji, D., Hammerling, G. J., Gati, C., Cerwenka, A. et al., Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin. PLoS Pathog. 2011. 7: e1002195.
18. Jarahian, M., Watzl, C., Fournier, P., Arnold, A., Djandji, D., Zahedi, S., Cerwenka, A. et al., Activation of natural killer cells by Newcastle disease virus hemagglutinin-neuraminidase. J. Virol. 2009. 83: 8108–8121.
19. Gur, C., Doron, S., Kfir-Erenfeld, S., Horwitz, E., Abu-Tair, L., Safadi, R. and Mandelboim, O., NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis. Gut 2012. 61: 885–893.
20. Gur, C., Enk, J., Weitman, E., Bachar, E., Suissa, Y., Cohen, G., Schyr, R. B. et al., The expression of the beta cell-derived autoimmune ligand for the killer receptor nkp46 is attenuated in type 2 diabetes. PLoS One 2013. 8: e74033.
21. Pessino, A., Sivori, S., Bottino, C., Malaspina, A., Morelli, L., Moretta, L., Biassoni, R. et al., Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J. Exp. Med. 1998. 188: 953–960.
22. Sivori, S., Pende, D., Bottino, C., Marcenaro, E., Pessino, A., Biassoni, R., Moretta, L. et al., NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur. J. Immunol. 1999. 29: 1656–1666.
23. Yossef, R., Gur, C., Shemesh, A., Guttman, O., Hadad, U., Nedvetzki, S., Miletic, A. et al., Targeting natural killer cell reactivity by employing antibody to NKp46: implications for type 1 diabetes. PLoS One 2015. 10: e0118936.
24. Costello, R. T., Sivori, S., Marcenaro, E., Lafage-Pochitaloff, M., Mozziconacci, M. J., Reviron, D., Gastaut, J. A. et al., Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood 2002. 99: 3661–3667.
25. Glasner, A., Ghadially, H., Gur, C., Stanietsky, N., Tsukerman, P., Enk, J. and Mandelboim, O., Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1. J. Immunol. 2012. 188: 2509–2515.
26. Gur, C., Porgador, A., Elboim, M., Gazit, R., Mizrahi, S., Stern-Ginossar, N. et al., The activating receptor NKp46 is essential for the development of type 1 diabetes. Nat. Immunol. 2010. 11: 121–128.
27. Wensveen, F. M., Jelencic, V., Valentic, S., Sestan, M., Wensveen, T. T., Theurich, S., Glasner, A. et al., NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat. Immunol. 2015. 16: 376–385.
28. Xepapadaki, P., Psarras, S., Bossios, A., Tsolia, M., Gourgiotis, D., Liapi-Adamidou, G., Constantopoulos, A. G. et al., Human Metapneumovirus as a causative agent of acute bronchiolitis in infants. J. Clin. Virol. 2004. 30: 267–270.
29. Falsey, A. R., Erdman, D., Anderson, L. J. and Walsh, E. E., Human metapneumovirus infections in young and elderly adults. J. Infect. Dis. 2003. 187: 785–790.
30. van den Hoogen, B. G., Herfst, S., Sprong, L., Cane, P. A., Forleo-Neto, E., de Swart, R. L., Osterhaus, A. D. et al., Antigenic and genetic variability of human metapneumoviruses. Emerg. Infect. Dis. 2004. 10: 658–666.
31. Biacchesi, S., Skiadopoulos, M. H., Boivin, G., Hanson, C. T., Murphy, B. R., Collins, P. L. and Buchholz, U. J., Genetic diversity between human metapneumovirus subgroups. Virology 2003. 315: 1–9.
32. Huck, B., Scharf, G., Neumann-Haefelin, D., Puppe, W., Weigl, J. and Falcone, V., Novel human metapneumovirus sublineage. Emerg. Infect. Dis. 2006. 12: 147–150.
33. Kahn, J. S., Epidemiology of human metapneumovirus. Clin. Microbiol. Rev. 2006. 19: 546–557.
34. Panda, S., Mohakud, N. K., Pena, L. and Kumar, S., Human metapneumovirus: review of an important respiratory pathogen. Int. J. Infect. Dis. 2014. 25: 45–52.
35. van den Hoogen, B. G., de Jong, J. C., Groen, J., Kuiken, T., de Groot, R., Fouchier, R. A. and Osterhaus, A. D., A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med. 2001. 7: 719–724.
36. Guerrero-Plata, A., Kolli, D., Hong, C., Casola, A. and Garofalo, R. P., Subversion of pulmonary dendritic cell function by paramyxovirus infections. J. Immunol. 2009. 182: 3072–3083.
37. Guerrero-Plata, A., Casola, A., Suarez, G., Yu, X., Spetch, L., Peeples, M. E. and Garofalo, R. P., Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus. Am. J. Respir. Cell Mol. Biol. 2006. 34: 320–329.
38. Kolli, D., Gupta, M. R., Sbrana, E., Velayutham, T. S., Chao, H., Casola, A. and Garofalo, R. P., Alveolar macrophages contribute to the pathogenesis of human metapneumovirus infection while protecting against respiratory syncytial virus infection. Am. J. Respir. Cell Mol. Biol. 2014. 51: 502–515.
39. Alvarez, R., Harrod, K. S., Shieh, W. J., Zaki, S. and Tripp, R. A., Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies. J. Virol. 2004. 78: 14003–14011.
40. Alvarez, R. and Tripp, R. A., The immune response to human metapneumovirus is associated with aberrant immunity and impaired virus clearance in BALB/c mice. J. Virol. 2005. 79: 5971–5978.
41. Herd, K. A., Mahalingam, S., Mackay, I. M., Nissen, M., Sloots, T. P. and Tindle, R. W., Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice. J. Virol. 2006. 80: 2034–2044.
42. Kolli, D., Bataki, E. L., Spetch, L., Guerrero-Plata, A., Jewell, A. M., Piedra, P. A., Milligan, G. N. et al., T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection. J. Virol. 2008. 82: 8560–8569.
43. Herd, K. A., Nelson, M., Mahalingam, S. and Tindle, R. W., Pulmonary infection of mice with human metapneumovirus induces local cytotoxic T-cell and immunoregulatory cytokine responses similar to those seen with human respiratory syncytial virus. J. Gen. Virol. 2010. 91: 1302–1310.
44. Wen, S. C., Tollefson, S. J., Johnson, M., Gilchuk, P., Boyd, K. L., Shepherd, B., Joyce, S. et al., Acute clearance of human metapneumovirus occurs independently of natural killer cells. J. Virol. 2014. 88: 10963–10969.
45. Sabo, Y., Ehrlich, M. and Bacharach, E., The conserved YAGL motif in human metapneumovirus is required for higher-order cellular assemblies of the matrix protein and for virion production. J. Virol. 2011. 85: 6594–6609.
46. Achdout, H., Arnon, T. I., Markel, G., Gonen-Gross, T., Katz, G., Lieberman, N., Gazit, R. et al., Enhanced recognition of human NK receptors after influenza virus infection. J. Immunol. 2003. 171: 915–923.
47. Corrales-Aguilar, E., Trilling, M., Reinhard, H., Merce-Maldonado, E., Widera, M., Schaal, H., Zimmermann, A. et al., A novel assay for detecting virus-specific antibodies triggering activation of Fcgamma receptors. J. Immunol. Methods 2013. 387: 21–35.
48. Aguado, E., Santamaria, M., Gallego, M. D., Pena, J. and Molina, I. J., Functional expression of CD43 on human natural killer cells. J. Leukoc. Biol. 1999. 66: 923–929.
49. Chiossone, L., Chaix, J., Fuseri, N., Roth, C., Vivier, E. and Walzer, T., Maturation of mouse NK cells is a 4-stage developmental program. Blood 2009. 113: 5488–5496.
50. Yokoyama, W. M. and Plougastel, B. F., Immune functions encoded by the natural killer gene complex. Nat. Rev. Immunol. 2003. 3: 304–316.
51. Brooks, A. G., Posch, P. E., Scorzelli, C. J., Borrego, F. and Coligan, J. E., NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor. J. Exp. Med. 1997. 185: 795–800.
52. Arase, H., Saito, T., Phillips, J. H. and Lanier, L. L., Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2). J. Immunol. 2001. 167: 1141–1144.
53. Matsumoto, N., Mitsuki, M., Tajima, K., Yokoyama, W. M. and Yamamoto, K., The functional binding site for the C-type lectin-like natural killer cell receptor Ly49A spans three domains of its major histocompatibility complex class I ligand. J. Exp. Med. 2001. 193: 147–158.
54. Freymouth, F., Vabret, A., Legrand, L., Eterradossi, N., Lafay-Delaire, F., Brouard, J. and Guillois, B., Presence of the new human metapneumovirus in French children with bronchiolitis. Pediatr. Infect. Dis. J. 2003. 22: 92–94.
55. Wolf, D. G., Zakay-Rones, Z., Fadeela, A., Greenberg, D. and Dagan, R., High seroprevalence of human metapneumovirus among young children in Israel. J. Infect. Dis. 2003. 188: 1865–1867.
56. von Linstow, M. L., Larsen, H. H., Eugen-Olsen, J., Koch, A., Nordmann Winther, T., Meyer, A. M., Westh, H. et al., Human metapneumovirus and respiratory syncytial virus in hospitalized Danish children with acute respiratory tract infection. Scand. J. Infect. Dis. 2004. 36: 578–584.
57. Williams, J. V., Tollefson, S. J., Johnson, J. E. and Crowe, J. E., Jr., The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity. J. Virol. 2005. 79: 10944–10951.
58. Williams, J. V., Harris, P. A., Tollefson, S. J., Halburnt-Rush, L. L., Pingsterhaus, J. M., Edwards, K. M., Wright, P. F. et al., Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N. Engl. J. Med. 2004. 350: 443–450.
59. Esper, F., Martinello, R. A., Boucher, D., Weibel, C., Ferguson, D., Landry, M. L. and Kahn, J. S., A 1-year experience with human metapneumovirus in children aged <5 years. J. Infect. Dis. 2004. 189: 1388–1396.
60. Bar-On, Y., Glasner, A., Meningher, T., Achdout, H., Gur, C., Lankry, D., Vitenshtein, A. et al., Neuraminidase-mediated, NKp46-dependent immune-evasion mechanism of influenza viruses. Cell Rep. 2013. 3: 1044–1050.
61. Seidel, E., Le, V. T., Bar-On, Y., Tsukerman, P., Enk, J., Yamin, R., Stein, N. et al., Dynamic co-evolution of host and pathogen: HCMV downregulates the prevalent allele MICA *008 to escape elimination by NK cells. Cell Rep. 2015 10: 968–982.
62. Herfst, S., de Graaf, M., Schickli, J. H., Tang, R. S., Kaur, J., Yang, C. F., Spaete, R. R. et al., Recovery of human metapneumovirus genetic lineages a and B from cloned cDNA. J. Virol. 2004. 78: 8264–8270.
63. Hu, A., Colella, M., Tam, J. S., Rappaport, R. and Cheng, S. M., Simultaneous detection, subgrouping, and quantitation of respiratory syncytial virus A and B by real-time PCR. J. Clin. Microbiol. 2003. 41: 149–154.